Breakthrough Technology Could Lead to One-Time HIV Treatment
TAU researchers demonstrate initial success in neutralizing the virus with a single vaccine Researchers from Tel Aviv University demonstrated the success of a novel technology that may be developed into a one-time vaccine to treat people with HIV and AIDS….
Hospitals in Delhi are fast-filling as patients with breathing problems increase
The impact of deteriorating air quality in the national capital is now visible in the outpatient departments of hospitals in the city. Cases of pollution-related ailments have spiked in the past few weeks, health experts said.Each year, as winter draws…
DCGI approved AstraZeneca’s Lynparza as a monotherapy for adjuvant treatment of patients with high-risk early breast cancer
AstraZeneca India, a leading science-led biopharmaceutical company, today announced that it has received a Drugs Controller General of India (DCGI) approval to market its drug Lynparza (Olaparib) as a monotherapy for the adjuvant treatment of adult patients with BRCA-mutated HER2-…
AstraZeneca partners with Alveofit to scale up the diagnosis and treatment of lung diseases in India.
Under the aegis of its A.Catalyst network, AstraZeneca India announced its partnership with Alveofit, a SaaS-IoT enabled respiratory healthcare platform, to offer IoT enabled handheld spirometers at hospitals across the country. This partnership aims to embed latest technological advancements in…
